Abstract
We investigated whether disturbance of glycocalyx integrity is related with increased cardiovascular risk. In 600 healthy subjects, we measured perfused boundary region (PBR), a marker of glycocalyx integrity, in sublingual microvessels with diameter ranging 5–25 µm using a dedicated camera (Sideview Darkfield Imaging). Increased PBR indicates reduced glycocalyx thickness. We prospectively monitored the occurrence of cardiovascular events (MACE-death, myocardial infarction, and stroke) during a 6-year follow-up. Fifty-seven MACE were documented. Increased values of PBR5-25 predicted higher risk for MACE in a model including sex, age, hyperlipidemia, diabetes, hypertension, smoking, family history of coronary disease, treatment with ACEi/ARBs, or lipid-lowering agents (hazard ratio (HR), 6.44, p = 0.011; net reclassification improvement (NRI), 28%; C-statistic: 0.761). PBR5-25 was an independent and additive predictor of outcome when added in a model including the European Heart SCORE, diabetes, family history of CAD, and medication (HR, 4.71; NRI: 39.7%, C-statistic from 0.653 to 0.693; p < 0.01).Glycocalyx integrity is an independent and additive predictor to risk factors for MACE at 6-year follow-up in individuals without cardiovascular disease. ClinicalTrials.govIdentifier:NCT04646252.
Graphical abstract
PBR5-25 was an independent and additive predictor of adverse cardiovascular events in a model including the European Heart SCORE, diabetes, family history of coronary disease, and medication (HR: 4.71, NRI: 39.7%, C-statistic from 0.653 to 0.693; p < 0.01, NRI:37.9%).
Similar content being viewed by others
Data Availability
The datasets generated and/or analyzed during the current study are not publicly available due to information that could compromise the privacy of research participants but are available from the corresponding author on reasonable request.
Code Availability
Not applicable.
Abbreviations
- ACEi/ARBs:
-
Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers
- AMI:
-
Acute myocardial infarction
- CAD:
-
Coronary artery disease
- DM:
-
Diabetes mellitus
- GLS:
-
Global longitudinal strain
- HF:
-
Heart failure
- HR:
-
Hazard ratio
- MACE:
-
Major adverse cardiovascular events
- NO:
-
Nitric oxide
- NRI:
-
Net reclassification improvement
- PAD:
-
Peripheral arterial disease
- PBR:
-
Perfused boundary region
- RBC:
-
Red blood cell
- SDF:
-
Sideview Darkfield
- TGs:
-
Triglycerides
References
Kapuku, G. K., Harshfield, G. A., Davis, H. C., & Treiber, F. A. (2006). Early markers of cardiovascular disease. Vascular Pharmacology, 45, 277–280.
Deanfield, J. E., & Halcox, J. P. (2007). Rabelink TJ Endothelial function and dysfunction: Testing and clinical relevance. Circulation, 115, 1285–1295.
Reitsma, S., Slaaf, D. W., Vink, H., van Zandvoort, M. A., & oudeEgbrink, M. G. (2007). The endothelial glycocalyx: composition, functions, and visualization. Pflugers Archiv, 454, 345–359.
Pries, A. R., Secomb, T. W., & Gaehtgens, P. (2005). The endothelial surface layer. Pflugers Archiv. European Journal of Physiology, 440, 653–666.
Weinbaum, S., Tarbell, J. M., & Damiano, E. R. (2007). The structure and function of the endothelial glycocalyx layer. Annual Review of Biomedical Engineering, 9, 121–167.
Levick, J. R. (2004). Revision of the Starling principle: New views of tissue fluid balance. Journal of Physiology, 557, 704.
Levick, J. R., & Michel, C. C. (2010). Microvascular fluid exchange and the revised Starling principle. Cardiovascular Research, 87, 198–210.
Tarbell, J. M. (2003). Mass transport in arteries and the localization of atherosclerosis. Annual Review of Biomedical Engineering, 5, 79–118.
Weinbaum, S., Zhang, X., Han, Y., Vink, H., & Cowin, S. C. (2003). Mechanotransduction and flow across the endothelial glycocalyx. Proceedings of the National Academy of Sciences of the United States of America, 100, 7988–7995.
Schmidt, E. P., Yang, Y., Janssen, W. J., Gandjeva, A., Perez, M. J., et al. (2012). The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nature Medicine, 18, 1217.
Vink, H., Constantinescu, A. A., & Spaan, J. A. (2000). Oxidized lipoproteins degrade the endothelial surface layer: Implications for platelet endothelial cell adhesion. Circulation, 101, 1500–1502.
Nieuwdorp, M., Meuwese, M. C., Vink, H., Hoekstra, J. B., Kastelein, J. J., & Stroes, E. S. (2005). The endothelial glycocalyx: A potential barrier between health and vascular disease. Current Opinion in Lipidology, 16, 507–511.
Nieuwdorp, M., Meuwese, M. C., Mooij, H. L., Ince, C., Broekhuizen, L. N., Kastelein, J. J., Troes, E. S., & Vink, H. (2008). Measuring endothelial glycocalyx dimensions in humans: A potential novel tool to monitor vascular vulnerability. Journal of Applied Physiology, 104, 845–852.
Goedhart, P. T., Khalilzada, M., Bezemer, R., & Merza, J. (2007). Ince C SidestreamDark Field (SDF) imaging: A novel stroboscopic LED ring-based imagingmodality for clinical assessment of the microcirculation. Optics Express, 15, 15101–15114.
Ikonomidis, I., Pavlidis, G., Lambadiari, V., Kousathana, F., Varoudi, M., Spanoudi, F., Maratou, E., Parissis, J., Triantafyllidi, H., & DimitriadisGLekakis, J. (2017). Early detection of left ventricular dysfunction in first-degree relatives of diabetic patients by myocardial deformation imaging: The role of endothelial glycocalyx damage. International Journal of Cardiology, 233, 105–112.
Lekakis, J., Abraham, P., Balbarini, A., Blann, A., Boulanger, C. M., Cockcroft, J., Cosentino, F., Deanfield, J., Gallino, A., Ikonomidis, I., Kremastinos, D., Landmesser, U., Protogerou, A., Stefanadis, C., Tousoulis, D., Vassalli, G., Vink, H., Werner, N., Wilkinson, I., & Vlachopoulos, C. (2011). Methods for evaluating endothelial function: A position statement from the European society of Cardiology Working Group on peripheral circulation. European Journal of Cardiovascular Prevention and Rehabilitation, 18, 775–789.
Mulders, T. A., Nieuwdorp, M., Stroes, E. S., Vink, H., & Pinto-Sietsma, S. J. (2013). Non-invasive assessment of microvascular dysfunction in families with premature coronary artery disease. International Journal of Cardiology, 168, 5026–5028.
Amraoui, F., OldeEngberink, R. H., van Gorp, J., Ramdani, A., Vogt, L., & van den Born, B. J. (2014). Microvascular glycocalyx dimension estimated by automated SDF imaging is not related to cardiovascular disease. Microcirculation, 21, 499–505.
Ikonomidis, I., Marinou, M., Vlastos, D., Kourea, K., Andreadou, I., Liarakos, N., Triantafyllidi, H., Pavlidis, G., Tsougos, E., & Parissis, J. (2017). Lekakis J Effects of varenicline and nicotine replacement therapy on arterial elasticity, endothelial glycocalyx and oxidative stress during a 3-month smoking cessation program. Atherosclerosis, 262, 123–130.
Valerio, L., Peters, R. J., Zwinderman, A. H., & Pinto-Sietsma, S. J. (2019). Sublingual endothelial glycocalyx and atherosclerosis. A cross-sectional study. PLoS One, 14, e0213097.
Ikonomidis, I., Voumvourakis, A., Makavos, G., Triantafyllidi, H., Pavlidis, G., Katogiannis, K., et al. (2018). Association of impaired endothelial glycocalyx with arterial stiffness, coronary microcirculatory dysfunction, and abnormal myocardial deformation in untreated hypertensives. Journal of Clinical Hypertension (Greenwich), 20, 672–679.
Lambadiari, V., Pavlidis, G., Kousathana, F., Maratou, E., Georgiou, D., Andreadou, I., Kountouri, A., Varoudi, M., Balampanis, K., Parissis, J., et al. (2019). Effects of different antidiabetic medications on endothelial glycocalyx, myocardial function, and vascular function in type 2 diabetic patients: One year follow-up study. Journal of Clinical Medicine, 8, 983.
Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Bohm, M., et al. (2013). 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension, 31, 1281–1357.
ADVANCE Collaborative Group, Patel, A., MacMahon, S., Chalmers, J., Neal, B., & Billot, L. (2008). Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine., 2008(358), 2560–2572.
Reiner, Z., Catapano, A. L., et al. (2011). ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal, 32, 1769–1818.
Mannan, H., Stevenson, C., Peeters, A., Walls, H., & McNeil, J. (2010). Framingham risk prediction equations for incidence of cardiovascular disease using detailed measures for smoking. Heart International, 5, e11.
Sivapalaratnam, S., Boekholdt, S. M., Trip, M. D., Sandhu, M. S., Luben, R., Kastelein, J. J., Wareham, N. J., & Khaw, K. T. (2010). Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study. Heart, 96, 1985–1989.
Conroy, R., Pyorala, K., Fitzgerald, A. P., Sans, S., Menotti, A., De Backer, G., De Bacquer, D., Ducimetie’re, P., Jousilahti, P., Keil, U., Njølstad, I., Oganov, R. G., Thomsen, T., Tunstall-Pedoe, H., Tverdal, A., Wedel, H., Whincup, P., Wilhelmsen, L., & Graham, I. (2003). Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal, 24, 987–1003.
Stronks, K., Kulu-Glasgow, I., & Agyemang, C. (2009). The utility of ’country of birth’ for the classification of ethnic groups in health research: The Dutch experience. Ethnicity & Health, 14, 255–269.
Lee DH, Dane MJC, van den Berg B.M., Boels M.G.S., van Teeffelen J. W., de Mutsert R., den Heijer M., Rosendaal F.R., van der Vlag J., Jan van Zonneveld A., Vink H., Rabelink T.J. Deeper penetration of erythrocytes into the endothelial glycocalyx is associated with impaired microvascular perfusion. PLoS One. 2014; 9:e96477.
Ikonomidis, I., Frogoudaki, A., Vrettou, A. R., Andreou, I., Palaiodimou, L., Katogiannis, K., Liantinioti, C., Vlastos, D., Zervas, P., Varoudi, M., Lambadiari, V., Triantafyllidi, H., Pavlidis, G., Efentakis, P., Tsoumani, M., Tsantes, A. E., Parissis, J., Revela, I., Andreadou, I., & Tsivgoulis, G. (2019). Impaired arterial elastic. Properties and endothelial glycocalyx in patients with embolic stroke of undetermined source. Thrombosis and Haemostasis, 119, 1860–1868.
Panagiotakos, D. B., Pitsavos, C., Chrysohoou, C., Skoumas, I., Stefanadis, C., & ATTICA Study. (2008). Five-year incidence of cardiovascular disease and its predictors in Greece: The ATTICA study. Vascular Medicine, 13, 113–121. .
Lachin, J. M., & Foulkes, M. A. (1986). Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics, 42, 507–519.
Hintze, J. (2011). PASS 11. NCSS, LLC. Kaysville, Utah, USA. www.ncss.com.
Nieuwdorp, M., van Haeften, T. W., Gouverneur, M. C., Mooij, H. L., van Lieshout, M. H., Levi, M., Meijers, J. C., Holleman, F., Hoekstra, J. B., Vink, H., et al. (2006). Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes, 55, 480–486.
Zuurbier, C. J., Demirci, C., Koeman, A., Vink, H., & Ince, C. (2005). Short-term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cells. J ApplPhysiol, 99, 1471–1476.
Machin, D. R., Gates, P. E., Vink, H., Frech, T. M., & Donato, A. J. (2017). Automated measurement of microvascular function reveals dysfunction in systemic sclerosis: A cross-sectional study. Journal of Rheumatology, 44, 1603–1611.
Ikonomidis, I., Pavlidis, G., Thymis, J., Birba, D., Kalogeris, A., Kousathana, F., Kountouri, A., Balampanis, K., Parissis, J., Andreadou, I., Katogiannis, K., Dimitriadis, G., Bamias, A., Iliodromitis, E., & Lambadiari, V. (2020). Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and their combination on endothelial glycocalyx, arterial function, and myocardial work index in patients with type 2 diabetes mellitus after 12-month treatment. Journal of the American Heart Association, 9, e015716.
Kaufmann, D., Szwoch, M., Kwiatkowska, J., Raczak, G., & Daniłowicz-Szymanowicz, L. (2019). Global longitudinal strain can predict heart failure exacerbation in stable outpatients with ischemic left ventricular systolic dysfunction. PLoS One, 14, e0225829.
Dekker, N. A. M., Veerhoek, D., Koning, N. J., van Leeuwen, A. L. I., Elbers, P. W. G., van den Brom, C. E., Vonk, A. B. A., & Boer, C. (2019). Postoperative microcirculatory perfusion and endothelial glycocalyx shedding following cardiac surgery with cardiopulmonary bypass. Anaesthesia, 74, 609–618.
Koning, N. J., Vonk, A. B., Vink, H., & Boer, C. (2016). Side-by-Side alterations in glycocalyx thickness and perfused microvascular density during acute microcirculatory alterations in cardiac surgery. Microcirculation, 23, 69–74.
Nussbaum, C., Haberer, A., Tiefenthaller, A., et al. (2015). Pertubation of the microvascular glycocalyx and perfusion in infants after cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery, 150, 1474–1481.
Ikonomidis, I., Vlastos, D., Andreadou, I., Gazouli, M., Efentakis, P., Varoudi, M., Makavos, G., Kapelouzou, A., Lekakis, J., Parissis, J., Katsanos, S., Tsilivarakis, D., Hausenloy, D. J., Alexopoulos, D., Cokkinos, D. V., Bøtker, H. E., & Iliodromitis, E. K. (2021). Vascular conditioning prevents adverse left ventricular remodeling after acute myocardial infarction: A randomised remote conditioning study. Basic Research in Cardiology, 116, 9.
Wadowski, P. P., Hülsmann, M., Schörgenhofer, C., Lang, I. M., Wurm, R., Gremmel, T., Koppensteiner, R., Steinlechner, B., Schwameis, M., & Jilma, B. (2018). Sublingual functional capillary rarefaction in chronic heart failure. European Journal of Clinical Investigation, 48, e12869.
Gorshkov, A. Y., Klimushina, M. V., Boytsov, S. A., Kots, A. Y., & Gumanova, N. G. (2018). Increase in perfused boundary region of endothelial glycocalyx is associated with higher prevalence of ischemic heart disease and lesions of microcirculation and vascular wall. Microcirculation, 25, e12454.
Martens, R. J. H., Vink, H., van Oostenbrugge, R. J., & Staals, J. (2013). Sublingual microvascular glycocalyx dimensions in lacunar stroke patients. Cerebrovascular Diseases, 35, 451–454.
Rovas, A., Osiaevi, I., Buscher, K., Sackarnd, J., Tepasse, P. R., Fobker, M., Kühn, J., Braune, S., Göbel, U., Thölking, G., Gröschel, A., Pavenstädt, H., Vink, H., & Kümpers, P. (2021). Microvascular dysfunction in COVID-19: The MYSTIC study. Angiogenesis, 24, 145–157.
Author information
Authors and Affiliations
Contributions
Authors contributions is as follows: (1) study conception and design (Ignatios Ikonomidis, John Thymis, Vaia Lambadiari); (2) laboratory measurements (Foteini Kousathana, Charilaos Triantafyllou, Gavriella Kostelli, Dimitrios Vlastos, Aikaterini Kountouri, Eftihia Polyzogopoulou); (3) data analysis and interpretation (Georgia-Angeliki Koliou, Panagiotis Simitsis, George Pavlidis, Konstantinos Katogiannis, Helen Triantafyllidi, Spiridon Katsanos); and (4) drafting of the manuscript (John Lekakis, John Parissis, Gerasimos Filippatos, Evangelia Papadavid). All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
The study was conducted according to the principles outlined in the Declaration of Helsinki and was approved by the Ethics Committee of Attikon University Hospital.
Consent to Participate
All participants signed an informed consent.
Consent for Publication
Not applicable.
Conflict of Interest
The authors declare no competing interests.
Additional information
Associate Editor Marat Fudim oversaw the review of this article.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ikonomidis, I., Thymis, J., Simitsis, P. et al. Impaired Endothelial Glycocalyx Predicts Adverse Outcome in Subjects Without Overt Cardiovascular Disease: a 6-Year Follow-up Study. J. of Cardiovasc. Trans. Res. 15, 890–902 (2022). https://doi.org/10.1007/s12265-021-10180-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-021-10180-2